FindTrial
Sign In

Study for optimized multidisciplinary diagonosis and treatment strategy for bone metastases of unknown origin

Study for optimized multidisciplinary diagonosis and treatment strategy for bone metastases of unknown origin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026785
Enrollment
Unknown
Registered
2019-10-22
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone tumor

Interventions

Case series:Optimized multidisciplinary diagonosis and treatmen

Sponsors

Shanghai Changzheng Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent; 2. Aged between 18 and 75 years; 3. Patient with bone metastases from unknown origin.

Exclusion criteria

Exclusion criteria: 1. The objects refused to sign the informed consent; 2. The primary cancer site is central nervous system or bone; 3. The patients refused to be followed up; 4. Mental, intellectual disabilities or other communication disorders.

Design outcomes

Primary

MeasureTime frame
overall survival;survival since treatment;progression free survival;neurologic function;Pain;complication;—

Countries

China

Contacts

Public ContactJianru Xiao

Department of Orthopaedic Oncology, Changzheng Hospital

jianruxiao83@163.com+86 13701785283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026